Dr. John K. Scott, MD
Family Medicine (Family Medicine Physician)
At a glance
- In the NPI registry since
- 2006
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Family Medicine Physician primary
VA license 0101233714
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Payments from drug and device companies
In 2025, 4 companies reported 58 payments worth $16,719 in total to this clinician.
| Eli Lilly and Company | $14,334 |
|---|---|
| Merck Sharp & Dohme LLC | $2,159 |
| Eisai Inc. | $146 |
| F. Hoffmann-la Roche AG | $80.00 |
| Food and Beverage | $10,769 |
|---|---|
| Travel and Lodging | $5,913 |
| Education | $36.00 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Eli Lilly and Company Feb 3, 2025 | Travel and Lodging travel to HOUSTON, GA · in-kind | $805 |
| Merck Sharp & Dohme LLC Sep 10, 2025 | Travel and Lodging CARDIOVASCULAR · travel to Phoenix, AZ · in-kind Company’s descriptionProvided as part of a clinical research engagement. | $689 |
| Eli Lilly and Company Apr 16, 2025 | Travel and Lodging travel to MIAMI, GA · in-kind | $424 |
| Eli Lilly and Company Apr 16, 2025 | Travel and Lodging travel to MIAMI, GA · in-kind | $379 |
| Merck Sharp & Dohme LLC Sep 10, 2025 | Travel and Lodging CARDIOVASCULAR · travel to Phoenix, AZ · in-kind Company’s descriptionProvided as part of a clinical research engagement. | $334 |
| Merck Sharp & Dohme LLC Sep 9, 2025 | Travel and Lodging CARDIOVASCULAR · travel to Phoenix, AZ · in-kind Company’s descriptionProvided as part of a clinical research engagement. | $334 |
| Eli Lilly and Company Feb 3, 2025 | Travel and Lodging travel to HOUSTON, TX · in-kind | $269 |
| Eli Lilly and Company Feb 3, 2025 | Travel and Lodging travel to HOUSTON, TX · in-kind | $269 |
| Eli Lilly and Company Apr 16, 2025 | Travel and Lodging travel to MIAMI, FL · in-kind | $249 |
| Eli Lilly and Company Apr 16, 2025 | Travel and Lodging travel to MIAMI, FL · in-kind | $249 |
All 47 payments other than meals, newest first
| Company | What it was for | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC Sep 17, 2025 | Travel and Lodging CARDIOVASCULAR · travel to Phoenix, AZ Company’s descriptionProvided as part of a clinical research engagement. | $45.00 |
| Merck Sharp & Dohme LLC Sep 10, 2025 | Travel and Lodging CARDIOVASCULAR · travel to Phoenix, AZ · in-kind Company’s descriptionProvided as part of a clinical research engagement. | $689 |
| Merck Sharp & Dohme LLC Sep 10, 2025 | Travel and Lodging CARDIOVASCULAR · travel to Phoenix, AZ · in-kind Company’s descriptionProvided as part of a clinical research engagement. | $334 |
| Merck Sharp & Dohme LLC Sep 10, 2025 | Travel and Lodging CARDIOVASCULAR · travel to Phoenix, AZ · in-kind Company’s descriptionProvided as part of a clinical research engagement. | $140 |
| Merck Sharp & Dohme LLC Sep 9, 2025 | Travel and Lodging CARDIOVASCULAR · travel to Phoenix, AZ · in-kind Company’s descriptionProvided as part of a clinical research engagement. | $334 |
| Merck Sharp & Dohme LLC Sep 9, 2025 | Travel and Lodging CARDIOVASCULAR · travel to Phoenix, AZ · in-kind Company’s descriptionProvided as part of a clinical research engagement. | $241 |
| Eli Lilly and Company Apr 16, 2025 | Travel and Lodging travel to MIAMI, GA · in-kind | $424 |
| Eli Lilly and Company Apr 16, 2025 | Travel and Lodging travel to MIAMI, GA · in-kind | $379 |
| Eli Lilly and Company Apr 16, 2025 | Travel and Lodging travel to MIAMI, FL · in-kind | $249 |
| Eli Lilly and Company Apr 16, 2025 | Travel and Lodging travel to MIAMI, FL · in-kind | $249 |
| Eli Lilly and Company Apr 16, 2025 | Travel and Lodging travel to MIAMI, FL · in-kind | $249 |
| Eli Lilly and Company Apr 16, 2025 | Travel and Lodging travel to MIAMI, FL · in-kind Company’s descriptionGROUND TRANSPORTATION EXPENSES FOR A RESEARCH RELATED MEETING WHICH MAY HAVE LASTED MULTIPLE DAYS | $218 |
| Eli Lilly and Company Apr 16, 2025 | Travel and Lodging travel to MIAMI, FL · in-kind Company’s descriptionGROUND TRANSPORTATION EXPENSES FOR A RESEARCH RELATED MEETING WHICH MAY HAVE LASTED MULTIPLE DAYS | $197 |
| Eli Lilly and Company Apr 16, 2025 | Travel and Lodging travel to MIAMI, FL · in-kind Company’s descriptionGROUND TRANSPORTATION EXPENSES FOR A RESEARCH RELATED MEETING WHICH MAY HAVE LASTED MULTIPLE DAYS | $176 |
| Eli Lilly and Company Apr 16, 2025 | Travel and Lodging travel to MIAMI, FL · in-kind Company’s descriptionGROUND TRANSPORTATION EXPENSES FOR A RESEARCH RELATED MEETING WHICH MAY HAVE LASTED MULTIPLE DAYS | $98.00 |
| Eli Lilly and Company Apr 16, 2025 | Travel and Lodging travel to MIAMI, FL · in-kind Company’s descriptionGROUND TRANSPORTATION EXPENSES FOR A RESEARCH RELATED MEETING WHICH MAY HAVE LASTED MULTIPLE DAYS | $57.00 |
| Eli Lilly and Company Apr 16, 2025 | Education in-kind | $36.00 |
| Eli Lilly and Company Apr 16, 2025 | Travel and Lodging travel to MIAMI, FL · in-kind | $32.37 |
| Eli Lilly and Company Apr 16, 2025 | Travel and Lodging travel to MIAMI, FL · in-kind | $17.43 |
| Eli Lilly and Company Apr 16, 2025 | Travel and Lodging travel to MIAMI, FL · in-kind | $17.43 |
| Eli Lilly and Company Apr 16, 2025 | Travel and Lodging travel to MIAMI, FL · in-kind Company’s descriptionGROUND TRANSPORTATION EXPENSES FOR A RESEARCH RELATED MEETING WHICH MAY HAVE LASTED MULTIPLE DAYS | $16.97 |
| Eli Lilly and Company Apr 16, 2025 | Travel and Lodging travel to MIAMI, FL · in-kind Company’s descriptionGROUND TRANSPORTATION EXPENSES FOR A RESEARCH RELATED MEETING WHICH MAY HAVE LASTED MULTIPLE DAYS | $15.30 |
| Eli Lilly and Company Apr 16, 2025 | Travel and Lodging travel to MIAMI, FL · in-kind | $14.94 |
| Eli Lilly and Company Apr 16, 2025 | Travel and Lodging travel to MIAMI, FL · in-kind | $14.94 |
| Eli Lilly and Company Apr 16, 2025 | Travel and Lodging travel to MIAMI, FL · in-kind Company’s descriptionGROUND TRANSPORTATION EXPENSES FOR A RESEARCH RELATED MEETING WHICH MAY HAVE LASTED MULTIPLE DAYS | $13.64 |
| Eli Lilly and Company Apr 16, 2025 | Travel and Lodging travel to MIAMI, FL · in-kind Company’s descriptionGROUND TRANSPORTATION EXPENSES FOR A RESEARCH RELATED MEETING WHICH MAY HAVE LASTED MULTIPLE DAYS | $11.99 |
| Eli Lilly and Company Apr 16, 2025 | Travel and Lodging travel to MIAMI, FL · in-kind Company’s descriptionGROUND TRANSPORTATION EXPENSES FOR A RESEARCH RELATED MEETING WHICH MAY HAVE LASTED MULTIPLE DAYS | $9.99 |
| Eli Lilly and Company Apr 16, 2025 | Travel and Lodging travel to MIAMI, FL · in-kind Company’s descriptionGROUND TRANSPORTATION EXPENSES FOR A RESEARCH RELATED MEETING WHICH MAY HAVE LASTED MULTIPLE DAYS | $7.65 |
| Eli Lilly and Company Apr 16, 2025 | Travel and Lodging travel to MIAMI, FL · in-kind Company’s descriptionGROUND TRANSPORTATION EXPENSES FOR A RESEARCH RELATED MEETING WHICH MAY HAVE LASTED MULTIPLE DAYS | $4.99 |
| Eli Lilly and Company Apr 16, 2025 | Travel and Lodging travel to MIAMI, FL · in-kind Company’s descriptionGROUND TRANSPORTATION EXPENSES FOR A RESEARCH RELATED MEETING WHICH MAY HAVE LASTED MULTIPLE DAYS | $4.99 |
| Eli Lilly and Company Apr 16, 2025 | Travel and Lodging travel to MIAMI, FL · in-kind Company’s descriptionGROUND TRANSPORTATION EXPENSES FOR A RESEARCH RELATED MEETING WHICH MAY HAVE LASTED MULTIPLE DAYS | $4.99 |
| Eli Lilly and Company Apr 16, 2025 | Travel and Lodging travel to MIAMI, FL · in-kind Company’s descriptionGROUND TRANSPORTATION EXPENSES FOR A RESEARCH RELATED MEETING WHICH MAY HAVE LASTED MULTIPLE DAYS | $4.99 |
| Eli Lilly and Company Apr 16, 2025 | Travel and Lodging travel to MIAMI, FL · in-kind Company’s descriptionGROUND TRANSPORTATION EXPENSES FOR A RESEARCH RELATED MEETING WHICH MAY HAVE LASTED MULTIPLE DAYS | $4.45 |
| Eli Lilly and Company Apr 16, 2025 | Travel and Lodging travel to MIAMI, FL · in-kind Company’s descriptionGROUND TRANSPORTATION EXPENSES FOR A RESEARCH RELATED MEETING WHICH MAY HAVE LASTED MULTIPLE DAYS | $2.49 |
| Eli Lilly and Company Apr 16, 2025 | Travel and Lodging travel to MIAMI, FL · in-kind Company’s descriptionGROUND TRANSPORTATION EXPENSES FOR A RESEARCH RELATED MEETING WHICH MAY HAVE LASTED MULTIPLE DAYS | $1.24 |
| Eli Lilly and Company Feb 3, 2025 | Travel and Lodging travel to HOUSTON, GA · in-kind | $805 |
| Eli Lilly and Company Feb 3, 2025 | Travel and Lodging travel to HOUSTON, TX · in-kind | $269 |
| Eli Lilly and Company Feb 3, 2025 | Travel and Lodging travel to HOUSTON, TX · in-kind | $269 |
| Eli Lilly and Company Feb 3, 2025 | Travel and Lodging travel to HOUSTON, TX · in-kind Company’s descriptionGROUND TRANSPORTATION EXPENSES FOR A RESEARCH RELATED MEETING WHICH MAY HAVE LASTED MULTIPLE DAYS | $121 |
| Eli Lilly and Company Feb 3, 2025 | Travel and Lodging travel to HOUSTON, TX · in-kind Company’s descriptionGROUND TRANSPORTATION EXPENSES FOR A RESEARCH RELATED MEETING WHICH MAY HAVE LASTED MULTIPLE DAYS | $60.00 |
| Eli Lilly and Company Feb 3, 2025 | Travel and Lodging travel to HOUSTON, TX · in-kind | $46.06 |
| Eli Lilly and Company Feb 3, 2025 | Travel and Lodging travel to HOUSTON, TX · in-kind | $45.73 |
| Eli Lilly and Company Feb 3, 2025 | Travel and Lodging travel to HOUSTON, TX · in-kind Company’s descriptionGROUND TRANSPORTATION EXPENSES FOR A RESEARCH RELATED MEETING WHICH MAY HAVE LASTED MULTIPLE DAYS | $9.38 |
| Eli Lilly and Company Feb 3, 2025 | Travel and Lodging travel to HOUSTON, TX · in-kind Company’s descriptionGROUND TRANSPORTATION EXPENSES FOR A RESEARCH RELATED MEETING WHICH MAY HAVE LASTED MULTIPLE DAYS | $4.68 |
| Eli Lilly and Company Feb 3, 2025 | Travel and Lodging travel to HOUSTON, TX · in-kind | $1.99 |
| Eli Lilly and Company Feb 3, 2025 | Travel and Lodging travel to HOUSTON, TX · in-kind Company’s descriptionGROUND TRANSPORTATION EXPENSES FOR A RESEARCH RELATED MEETING WHICH MAY HAVE LASTED MULTIPLE DAYS | $1.49 |
| Eli Lilly and Company Feb 3, 2025 | Travel and Lodging travel to HOUSTON, TX · in-kind Company’s descriptionGROUND TRANSPORTATION EXPENSES FOR A RESEARCH RELATED MEETING WHICH MAY HAVE LASTED MULTIPLE DAYS | $0.74 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 14 industry-funded studies in 2025, from 10 companies. The companies reported $1,384,144 in research payments for these studies, mostly to the institutions running them.
- A Placebo-Controlled, Double-Blind, Parallel-Treatment Arm, 216 Week Study to Evaluate Efficacy and Safety of Treatment With BAN2401 in Subjects With Preclinical Alzheimer's Disease and Elevated Amyloid (A45 Trial) an…
Eisai Inc. - A Randomized, Double-blind, Placebo-controlled, Global Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986446, an Anti-MTBR Tau Monoclonal Antibody, in Participants with Early Alzheimers Disease (Targe…
E.r. Squibb & Sons, L.l.c. - A Placebo-Controlled, Double-Blind, Parallel-Group, 18-Month Study With an Open-Label Extension Phase to Confirm Safety and Efficacy of BAN2401 in Subjects With Early Alzheimer's Disease
Eisai Inc. - A phase 3A, observer-blind, randomized, controlled study to evaluate t
GlaxoSmithKline, LLC. - Study name not reported
Novo Nordisk As - Study of the Safety of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants From Approximately 2 Months of Age
Sanofi Pasteur Inc. · Active, not recruiting · NCT06824194 - A Phase 3b/4 Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Verify the Clinical Benefit of Aducanumab (BIIB037) in Participants With Alzheimer's Disease
Biogen, Inc. - Study name not reported
Novo Nordisk As - A phase 3,global,randomized,modified double blind,placebo controlled,study to evaluate the efficacy,immunogenicity,and safety of IVX A12,a respiratory syncytial virus RSV and human metapneumovirus hMPV virus like part…
AstraZeneca Pharmaceuticals LP - A Study of mRNA-1345, an mRNA Vaccine Targeting Respiratory Syncytial Virus, in Children 2 to <18 Years of Age at High Risk of Respiratory Syncytial Virus
ModernaTX, Inc. · Completed · NCT06097299
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.